Komori
Achilles (5142) · InitiativeElimination of tax loss carryforwards and continuation of Category 4 classification

Review of Assumptions Used in Accounting Estimates Regarding the Impact of COVID-19

First written in FY2021-Q3. 7 of 12 entries say "Restated". Latest entry: FY2026.

12entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2024-Q1AdvancedFY20242021: 420212022: 320222023: 220232024: 220242025: 020252026: 12026
Same theme, other companies
Accounting Estimates Based on Assumptions Regarding COVID-19A theme 597 companies write about · 468 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 600 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Elimination of tax loss carryforwards and continuation of Category 4 classificationAnnual report

    「As a result, profit and loss improved substantially and taxable income was generated, fully eliminating the tax loss carryforwards. However, in light of the material tax losses incurred during the past 3 years, we continue to classify the company as Category 4 for the current consolidated fiscal year.」

    Tax loss carryforwards were fully eliminated as performance improved, but the company classification for assessing the recoverability of deferred tax assets remains Category 4 in light of the material losses incurred during the past 3 years.
  2. FY2024AdvancedAnnual report

    「Because the recovery in performance is expected to take longer from the next fiscal year onward than assumed in the previous consolidated fiscal year, we revised our future profit plan. As a result, it is difficult to expect taxable income before adjustments for temporary differences and other items to arise for approximately the next 5 years, and we have changed the company classification to Category 4.」

    The company classification was changed to Category 4 based on the expected delay in the recovery of performance, and ¥3,093 million was recorded as income taxes—deferred, including the write-down of deferred tax assets.
  3. FY2024-Q3ReframedAnnual report

    「During the third quarter of the current consolidated fiscal year, we changed the assumptions used to estimate the future profit and loss plan for the previous consolidated fiscal year, taking into account the current business environment and expected future performance trends. Following this change in assumptions, we changed the company classification after careful consideration based on the “Guidance on Recoverability of Deferred Tax Assets.” Including the write-down of deferred tax assets resulting from this change, we recorded ¥2,729 million as income taxes—deferred.」

    The accounting-estimate theme has expanded from assumptions based on the impact of infectious diseases to the impact on tax effects, including changes in assumptions regarding the business environment, performance trends and sales volumes by product, a change in company classification, and the write-down of ¥2,729 million in deferred tax assets.
  4. FY2024-Q1RestatedAnnual report

    「There have been no material changes to the accounting estimates and the assumptions used in those estimates described under “Management's Analysis of Financial Position, Operating Results and Cash Flows” in the securities report for the previous fiscal year.」

    The company states that there have been no material changes from the previous fiscal year in its accounting estimates or the assumptions used in making them.
  5. FY2023-Q3RestatedAnnual report

    「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “5. Accounting Information, 1. Consolidated Financial Statements, etc., (1) Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the annual securities report for the previous fiscal year.」

    The company reconfirmed that there had been no material changes from the previous fiscal year in the assumptions used in accounting estimates concerning the impact of COVID-19.
  6. FY2023-Q2RestatedAnnual report

    「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “5. Accounting Information, 1. Consolidated Financial Statements, etc., (1) Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the annual securities report for the previous fiscal year.」

    The company reconfirmed that there had been no material changes from the previous fiscal year in the assumptions used in accounting estimates concerning the impact of COVID-19.
  7. FY2023-Q1RestatedAnnual report

    「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “5. Accounting Information, 1. Consolidated Financial Statements, etc., (1) Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the annual securities report for the previous fiscal year.」

    The company reconfirmed that there had been no material changes from the previous fiscal year in the assumptions used in accounting estimates concerning the impact of COVID-19.
  8. FY2022RestatedAnnual report

    「The company uses an estimated recoverability period of 5 years.」

    Based on the assumption that the impact of infectious diseases will continue, the company evaluated the next fiscal year's budget and the recoverability of deferred tax assets, continuing to use an estimated recoverability period of 5 years.
  9. FY2022-Q2RestatedAnnual report

    「There have been no material changes from the assumptions described in the previous fiscal year's annual securities report under “Part 5 Financial Information, 1 Consolidated Financial Statements, (1) Consolidated Financial Statements, Notes to Consolidated Financial Statements (Significant Accounting Estimates), 2 Recoverability of Deferred Tax Assets,” including assumptions concerning the future spread of COVID-19 and when it will subside.」

    The company reconfirmed that there had been no material changes from the previous fiscal year in the assumptions used in accounting estimates concerning the impact of COVID-19.
  10. FY2022-Q1RestatedAnnual report

    「There have been no material changes from the assumptions described in the previous fiscal year's annual securities report under “Part 5 Financial Information, 1 Consolidated Financial Statements, (1) Consolidated Financial Statements, Notes to Consolidated Financial Statements (Significant Accounting Estimates), 2 Recoverability of Deferred Tax Assets,” including assumptions concerning the future spread of COVID-19 and when it will subside.」

    The company reconfirmed that there had been no material changes from the previous fiscal year in the assumptions used in accounting estimates concerning the impact of COVID-19.
  11. FY2021AdvancedAnnual report

    「The budget for the next consolidated fiscal year was prepared based on the assumption that the impact of COVID-19 would continue, with the profit or loss of each business formulated accordingly. The company uses an estimated recoverability period of 5 years.」

    Based on the assumption that the impact of infectious diseases will continue, the company evaluated the next fiscal year's budget and the recoverability of deferred tax assets, specifying an estimated recoverability period of 5 years.
  12. FY2021-Q3First statedAnnual report

    「However, in light of the reissuance of a state of emergency in January 2021 following a resurgence of COVID-19 infections in Japan and the resulting inability to foresee when the spread of infections would subside, the company revised its assumption to “the impact of COVID-19 will continue for the time being,” and recognized deferred tax assets after considering their recoverability.」

    In light of the inability to foresee when the infectious disease would subside, the company for the first time identified as an independent theme its accounting response of revising its previous recovery assumptions and considering and recognizing the recoverability of deferred tax assets.
Moved together

"Accelerating the Process from New Product Development to Commercialization" moved the same way as this thread, in the same document, in 2 of its 12 moves.

2222★1234
  1. ★This thread
  2. 1Accelerating the Process from New Product Development to Commercialization2×
  3. 2Human Resources and Organizational Reform2×
  4. 3Research and New Product Development Centered on Core Technologies2×
  5. 4Using Retained Earnings for Growth Investment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Achilles yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Review of Assumptions Used in Accounting Estimates Regarding the Impact of COVID-19 | Achilles Corporation (5142) | Komori